Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

LAG3 anticorps (CF®488A)

Cet anticorps Souris Monoclonal détecte spécifiquement LAG3 dans . Il présente une réactivité envers Humain.
N° du produit ABIN7656421

Aperçu rapide pour LAG3 anticorps (CF®488A) (ABIN7656421)

Antigène

Voir toutes LAG3 Anticorps
LAG3 (Lymphocyte-Activation Gene 3 (LAG3))

Reactivité

  • 106
  • 39
  • 9
  • 4
  • 3
  • 2
  • 1
  • 1
  • 1
Humain

Hôte

  • 56
  • 47
  • 12
  • 4
  • 2
  • 1
Souris

Clonalité

  • 66
  • 53
  • 2
Monoclonal

Conjugué

  • 65
  • 9
  • 6
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp LAG3 est conjugé à/à la CF®488A

Application

Veuillez nous consulter SVP

Clone

LAG3-3261
  • Fonction

    Lymphocyte Activation Gene 3 (LAG-3) (Negative Checkpoint Regulator)(LAG3/3261), CF488A conjugate

    Attributs du produit

    LAG-3 (also called CD223) is a high affinity MHC class II ligand present on the surface of CD4 CD8 T cells and NK cell, with shared homology in structure to CD4 Molecules. It has a glutamic acid-proline (EP) repetitive sequence found in other functionally distinct mammalian, parasitic, and bacterial proteins that may influence a conserved biological function. LAG-3 CD4 CD8 T cells can associate with the T cell receptor (TCR) and downregulate TCR signaling in vitro. LAG-3 inhibits CD4-dependent T cell function via its cytoplasmic domain. LAG-3 Lys-468 within a conserved 'KIEELE' motif is essential for interaction with downstream signaling molecules. Furthermore, as a checkpoint inhibitor target, it may be superior to CTLA-4 and PD-1 since both antibodies only activate effector T-cells, whereas an antagonist LAG-3 antibody can both activate T effector cells (by downregulating the LAG-3 inhibiting signal into pre-activated LAG-3 cells) and inhibit induced (i. e. antigen-specific) Treg suppressive activity. Primary antibodies are available purified, or with a selection of fluorescent CF® Dyes and other labels. CF® Dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.

    Immunogène

    Recombinant full-length human LAG3 protein

    Isotype

    IgG2a, kappa
  • Indications d'application

    For coating for ELISA, order Ab without BSA. Higher concentration may be required for direct detection using primary antibody conjugates than for indirect detection with secondary antibody. Optimal dilution and staining procedure for a specific application should be determined by user. Recommended starting concentrations for titration are 1-2 μg/mL for most applications, or 1 μg/million cells/100 μLfor flow cytometry

    Commentaires

    Positive Control: Human tonsil or Hodgkin lymphoma (IHC-P).

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    0.1 mg/mL

    Buffer

    PBS, 0.1 % BSA, 0.05 % azide

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Conseil sur la manipulation

    Protect from light

    Stock

    4 °C

    Stockage commentaire

    Stable at room temperature or 37°C for 7 days.

    Protect from light

    Store at 2 to 8°C. Protect fluorescent conjugates from light

    Date de péremption

    24 months
  • Antigène

    LAG3 (Lymphocyte-Activation Gene 3 (LAG3))

    Autre désignation

    Lymphocyte Activation Gene 3

    Sujet

    Synonyms: CD223, FDC protein, LAG-3

    Gene Symbol: LAG3

    Tissue Expression: NK cells|T-cells

    Poids moléculaire

    70 kDa

    ID gène

    3902

    UniProt

    P18627

    Pathways

    Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints
Vous êtes ici:
Chat with us!